Tehran University of Medical Sciences Iranian Journal of Public Health 2251-6085 45 9 2016 10 10 1217 1219 Omid MOZAFARI Dept. of Traditional Persian Medicine, School of Medicine, Student Research Committe, Mazandaran University of Medical Sciences, Sari, Iran AND Dept. of Traditional Persian Medicine, School of Medicine, Golestan University of Medical Sciences, Gorgan, Iran Seyed Afshin SHOROFI Traditional and Complementary Medicine Research Center, Mazandaran University of Medical Sciences, Sari, Iran Seyde Sedighe YOUSEFI Traditional and Complementary Medicine Research Center, Mazandaran University of Medical Sciences, Sari, Iran 2016 09 27 2016 09 27 Pentavalent antimonials are still the first drug of choice for the treatment of cutaneous leishmaniasis (CL). Like other treatments, they can cause adverse reactions including musculoskeletal pain, gastrointestinal disturbances, and mild to moderate headaches. In this paper, we report the first case of an infant who developed acute urticaria after her mother’s parenteral use of meglumine antimoniate (glucantime).     https://ijph.tums.ac.ir/index.php/ijph/article/view/7857 https://ijph.tums.ac.ir/index.php/ijph/article/download/7857/5558